comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-06 04:27:14 - browse：47

Senate Health, Education, Labor, and Pensions Chair Sen. Bernie Sanders, I-Vt., points toward a poster detailing what he said the U.S. versus the "Rest of the World" spends on prescription drugs, during a hearing to examine the cost of prescription drugs. -- health policy coverage — Sen. Bernie Sanders (I-Vt.) raises his hand at a Thursday hearing on Capitol Hill in Washington to examine the cost of prescription drugs. Jacquelyn Martin/AP

WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater.

The hearing, featuring Merck CEO Robert Davis, Johnson & Johnson CEO Joaquin Duato, and Bristol Myers Squibb CEO Chris Boerner, was designed to draw public interest, and in that respect, it worked. The wood-paneled hearing room in a Senate office building was standing room only, with an overflow room prepared. Photographers flocked for photos as Sanders shook hands with each executive, standard practice before such hearings begin.

Sanders’ staff got an arm workout switching out foam boards behind the chairman’s head, illustrating how the drug companies called to testify make more revenue from the United States on certain medications than the rest of the world combined.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： First U.S. drug developed to treat liver disease MASH is approved

WSS

What is artificial intelligence? Experts weigh in

FDA advisers back CAR

UCLA team creates talking throat patch for voice disorders

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

hotspot

comprehensive

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Pfizer's RSV vaccine recommended for approval in Europe

Heart attack and stroke risk calculators need revising

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Hepatitis C has a cure — but many Americans still lack access to it

First U.S. drug developed to treat liver disease MASH is approved

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Amid AI frenzy, a top HHS official's quest to create safeguards

Hepatitis C has a cure — but many Americans still lack access to it

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

focus

First U.S. drug developed to treat liver disease MASH is approved

FDA advisers back CAR

How many hemophilia patients actually want gene therapy?

Amid AI frenzy, a top HHS official's quest to create safeguards

First U.S. drug developed to treat liver disease MASH is approved

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

explore

explore

knowledge

explore